COFACE SA: Disclosure of trading in own shares (excluding the liquidity agreement) made on February 21, 2025
Paris, 25 February – 17.45
Pursuant to Regulation (EU) No 596/2014 of 16 April 2014 on market abuse1
The main features of the 2024-2025 Share Buyback Program have been published on the Company’s website (http://www.coface.com/Investors/Disclosure-requirements, under “Own share transactions”) and are also described in the 2023 Universal Registration Document.
- Trading session of (Date): 21/02/2025
- Number of shares: 10,000
- Weighted average price: 16.0826 €
- Gross amount: 160,826.70 €
- MIC: XPAR
- Purpose of buyback: LTIP
CONTACTS
ANALYSTS / INVESTORS
Thomas JACQUET: +33 1 49 02 12 58 – [email protected]
Rina ANDRIAMIADANTSOA: +33 1 49 02 15 85 – [email protected]
FINANCIAL CALENDAR 2025
(subject to change)
Q1-2025 results: 5 May 2025 (after market close)
Annual General Shareholders’ Meeting: 14 May 2025
H1-2025 results: 31 July 2025 (after market close)
9M-2025 results: 3 November 2025 (after market close)
FINANCIAL INFORMATION
This press release, as well as COFACE SA’s integral regulatory information, can be found on the Group’s website: http://www.coface.com/Investors
For regulated information on Alternative Performance Measures (APM), please refer to our Interim Financial Report for H1-2024 and our 2023 Universal Registration Document (see part 3.7 “Key financial performance indicators”).
| Regulated documents posted by COFACE SA have been secured and authenticated with the blockchain technology by Wiztrust. You can check the authenticity on the website www.wiztrust.com. |
|
COFACE: FOR TRADE
www.coface.com
COFACE SA is listed in Compartment A of Euronext Paris
|
1 Also in pursuant to Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (and updates); Article L.225-209 and seq. of the French Commercial Code; Article L.221-3, Article L.241-1 and seq. of the General Regulation of the French Market Authority (AMF); AMF Recommendation DOC-2017-04 Guide for issuers on their own shares transactions and for stabilization measures.
Attachment
- 2025 02 25 – Declaration – Own shares transaction
